Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Grants & Contracts
Research output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Multi-Center, Randomized, Rater-Blind, Parallel-Group, Active Controlled Study to Evaluate the Benefits of Switching Therapy (Glatiramer Acetate or Interferon B-1a) to Natalizumab in Subjects with Relapsing Multiple Sclerosis
Berger, Joseph
(PI)
Neurology
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
5/17/10
→
1/31/12
View all
View less